Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Price:
927.8
INR
-0.93%
Market Closed
Market Cap:
₹933.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
IN |
|
Wanka Online Inc
HKEX:1762
|
CN |
Cash Flow Statement
Cash Flow Statement
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
Currency: INR
| Mar-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
14 954
|
22 848
|
36 429
|
28 381
|
28 038
|
25 897
|
36 023
|
48 089
|
56 431
|
60 267
|
64 641
|
|
| Depreciation & Amortization |
6 965
|
7 248
|
10 923
|
7 361
|
7 311
|
7 227
|
7 242
|
7 641
|
8 490
|
9 158
|
10 069
|
|
| Other Non-Cash Items |
7 681
|
5 070
|
6 694
|
(1 627)
|
(4 254)
|
5 163
|
6 087
|
(999)
|
(20)
|
2 425
|
1 514
|
|
| Cash Taxes Paid |
3 025
|
3 450
|
6 967
|
6 746
|
5 321
|
5 920
|
9 461
|
12 858
|
14 773
|
18 019
|
20 723
|
|
| Cash Interest Paid |
0
|
0
|
547
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 055
|
|
| Change in Working Capital |
(4 546)
|
(3 315)
|
(10 319)
|
(13 333)
|
(10 898)
|
(11 399)
|
(11 626)
|
(22 708)
|
(18 903)
|
(3 917)
|
(32 835)
|
|
| Cash from Operating Activities |
25 054
N/A
|
31 851
+27%
|
43 727
+37%
|
20 782
-52%
|
20 197
-3%
|
26 888
+33%
|
37 726
+40%
|
32 023
-15%
|
45 998
+44%
|
67 933
+48%
|
43 389
-36%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
(9 041)
|
(8 540)
|
(14 603)
|
(12 026)
|
(11 275)
|
(10 309)
|
(9 648)
|
(9 066)
|
(14 155)
|
(17 126)
|
(16 061)
|
|
| Other Items |
(1 082)
|
1 315
|
25 494
|
23 570
|
(693)
|
25 659
|
23 301
|
(5 686)
|
(13 321)
|
(66 597)
|
(99 772)
|
|
| Cash from Investing Activities |
(10 123)
N/A
|
(7 225)
+29%
|
10 891
N/A
|
11 544
+6%
|
(11 968)
N/A
|
15 350
N/A
|
13 653
-11%
|
(14 752)
N/A
|
(27 476)
-86%
|
(83 723)
-205%
|
(115 833)
-38%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
0
|
9 866
|
9 866
|
0
|
(8 632)
|
(8 632)
|
0
|
(7 250)
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(3 489)
|
(32 107)
|
(32 525)
|
(3 850)
|
(22 110)
|
(31 439)
|
(22 797)
|
(3 915)
|
(23)
|
24 062
|
82 765
|
|
| Cash Paid for Dividends |
(7 166)
|
(15)
|
(3 601)
|
(3 722)
|
(2 804)
|
(2 671)
|
(6 210)
|
(6 210)
|
(3 032)
|
(3 025)
|
(11 053)
|
|
| Other |
(287)
|
(3 233)
|
(3 780)
|
(1 111)
|
(1 224)
|
(1 262)
|
(810)
|
(413)
|
(658)
|
(895)
|
(1 813)
|
|
| Cash from Financing Activities |
(10 942)
N/A
|
(25 489)
-133%
|
(30 040)
-18%
|
(8 683)
+71%
|
(34 770)
-300%
|
(44 004)
-27%
|
(29 817)
+32%
|
(17 788)
+40%
|
(10 963)
+38%
|
20 142
N/A
|
69 899
+247%
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(42)
|
(33)
|
86
|
64
|
66
|
79
|
(231)
|
(408)
|
(214)
|
747
|
|
| Net Change in Cash |
3 989
N/A
|
(905)
N/A
|
24 545
N/A
|
23 729
-3%
|
(26 477)
N/A
|
(1 700)
+94%
|
21 641
N/A
|
(748)
N/A
|
7 151
N/A
|
4 138
-42%
|
(1 798)
N/A
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
16 013
N/A
|
23 311
+46%
|
29 124
+25%
|
8 756
-70%
|
8 922
+2%
|
16 579
+86%
|
28 078
+69%
|
22 957
-18%
|
31 843
+39%
|
50 807
+60%
|
27 328
-46%
|
|
Switch to:
Switch to:
See Also
Discover More
